Roadzen, Inc. (RDZNW) Analyse boursière

Présentation de l'entreprise

Roadzen, Inc. (RDZNW) operates as an Insurtech company providing underwriting solutions across India, the United States, the United Kingdom, and Europe. The firm focuses on car, driver, and fleet underwriting, alongside road safety applications that utilize app-based and computer vision-based telematics for accident prevention, distraction alerts, and driver behavior monitoring. Although the specific sector and industry classifications are listed as N/A in available data, the company's operational scope clearly positions it within the financial technology and insurance technology landscape. The company employs 294 individuals to support its global operations, reflecting a mid-sized organizational structure for an Insurtech provider. Regarding its scale, the available market capitalization data is listed as N/A, which suggests the stock may trade with low liquidity or be classified as a micro-cap entity where standard large-cap metrics are not readily calculated or disclosed. The annual revenue stands at $50.30M, indicating that while the company has achieved significant top-line traction, it remains in a growth phase where profitability is yet to be realized. The absence of a defined market cap figure, combined with the relatively modest revenue base, indicates that Roadzen, Inc. is currently establishing its market position and has not yet achieved the scale of large, established public corporations.

Santé financière

The company reported a trailing twelve-month revenue of $50.30M, yet it incurred a net income loss of $-15,397,989, highlighting a significant disconnect between top-line sales and bottom-line profitability. Additionally, the EBITDA stood at $-9,694,687, which reveals that the company's cost structure is currently expansive, with operating expenses consuming the majority of its generated revenue. The free cash flow is reported at $-18,143,374, indicating that the company is burning cash rather than generating liquidity, which limits its immediate financial flexibility for capital expenditures or acquisitions without external financing. Gross margin is calculated at 60.9%, suggesting that the company retains a substantial portion of revenue after covering the direct costs of goods sold, which is a positive indicator for pricing power or low variable costs. However, the operating margin is -16.5% and the profit margin is -30.6%, demonstrating that high overhead costs are severely impacting operational efficiency and net profitability. On the balance sheet, the company holds $5.62M in cash but carries $29.93M in debt, creating a net debt position that must be managed carefully. The debt-to-equity ratio is listed as N/A, likely due to the negative equity position implied by the losses, making traditional leverage analysis difficult. The current ratio is 0.54, which indicates that current assets are insufficient to cover current liabilities, pointing to potential short-term liquidity constraints. Return on Equity is N/A due to negative equity, while Return on Assets is -19.4%, revealing that the company's asset base is generating negative returns rather than value for stakeholders.

Évaluation de la valorisation

The trailing P/E and forward P/E ratios are both listed as N/A, which is consistent with the company's negative earnings and pre-profitability status, making traditional earnings-based valuation multiples inapplicable. The price-to-book ratio is -0.37, indicating that the market values the company's equity at a significant discount relative to its book value, a common characteristic for loss-making companies or those with negative shareholder equity. The price-to-sales ratio and EV/EBITDA are also listed as N/A, suggesting that analysts cannot apply standard multiple comparisons given the lack of positive earnings or normalized sales multiples in the current dataset. The stock's 52-week high and low are both recorded at $0.12, meaning the current trading price is effectively flat relative to this narrow range. The beta value is 0.51, which signifies that the stock's price volatility is approximately half that of the broader market, implying lower systematic risk but also lower potential for price appreciation during bullish market cycles. This low beta, combined with the narrow trading range, suggests the stock is relatively stable in terms of price fluctuation but lacks the momentum often seen in high-growth technology stocks. The negative price-to-book further reinforces that the market is pricing in significant operational risks or expects a long turnaround period before the company can generate positive equity value.

Growth & Income

Revenue growth year-over-year is 18.8%, demonstrating strong top-line expansion and successful market penetration within the Insurtech sector. Earnings growth is listed as N/A due to the company's lack of profitability, which implies that earnings are not yet growing alongside revenue as the firm prioritizes market share acquisition over immediate profit realization. The company does not pay dividends, as the dividend yield and payout ratio are both N/A, indicating that all available cash is being retained to fund operations and reduce the existing debt load. Since the company is not a dividend payer, it reinvests its limited cash reserves and any future earnings directly into business growth initiatives rather than distributing income to shareholders. The overall growth and income profile is characterized by robust revenue expansion without current profitability or dividend distribution, typical of early-stage Insurtech companies investing heavily in technology development and customer acquisition.